Moreover, Wang et al demonstrated that IGF-I improves diabetic cardiomyopathy as a serious complication of diabetes mellitus via antioxidative and anti-inflammatory mechanisms, as well as with regulation of the Akt/GSK-3 signaling pathway.39 This evidence concerns the gene AKT1 and diabetic cardiomyopathy.